[The roles of activated protein-1 and cell cycle protein in silica-induced cell cycle changes]

Xiao-wei Jia1, Bing-ci Liu, Meng Ye

  • 1National Institute of Occupation Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

Abstract

Insights

Silica exposure increases cyclin D1 and CDK4, altering cell cycle progression in human embryonic lung fibroblasts. This occurs via the AP-1/cyclin D1 pathway, impacting cell division.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Toxicology

Context:

  • Silica exposure is a known occupational hazard.
  • Understanding cellular responses to silica is crucial for developing protective strategies.
  • Human embryonic lung fibroblasts (HELFs) are a relevant model for studying silica's effects.

Purpose:

  • To investigate the roles of cyclin D1 and CDK4 in silica-induced cell cycle alterations in HELFs.
  • To elucidate the signaling pathway involved in silica's impact on cell cycle progression.

Summary:

  • Silica exposure significantly upregulated cyclin D1 and CDK4 expression while downregulating E2F-4 in HELFs.
  • Silica induced cell cycle changes, with decreased G1 phase and increased S phase proportions.
  • The AP-1/cyclin D1 pathway was identified as the mechanism driving silica-induced cell cycle modifications.

Impact:

  • This study reveals a key molecular mechanism by which silica disrupts normal cell cycle regulation.
  • Findings provide insights into the pathogenesis of silica-related lung diseases.
  • Identifies potential therapeutic targets for mitigating silica toxicity.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.